| Dr Karen A Rizzo, MD | |
|
930 Red Rose Ct, Suite 301, Lancaster, PA 17601-1981 | |
| (717) 517-9083 | |
| (717) 517-9243 |
| Full Name | Dr Karen A Rizzo |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 39 Years |
| Location | 930 Red Rose Ct, Lancaster, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982704607 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | MD036713E (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lancaster General Hospital | Lancaster, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lancaster Ear Nose And Throat Llc | 1557527017 | 2 |
News Archive
iTrace for Blood Centers, (Version 1.0.924.0), the first application to use Radio Frequency Identification technology in blood establishments to assist in enhancing blood safety by preventing the release of unsuitable blood components, was cleared today by the U.S. Food and Drug Administration.
Debt projections released Tuesday by the Congressional Budget Office illustrate three fiscal paths: dangerous, dumb and smart. ... President Obama has called for a balanced solution but has neither proposed serious tax reform nor adequately outlined the ways in which he would get entitlement spending, particularly Medicare, under control. The position of most Republicans, on the presidential campaign trail and in Congress, is wildly less responsible.
Local physicians from Tri-Valley Medical Group recently spent a week in Washington D.C. to discuss the fundamental issues impacting the roll-out of health care reform - and came away with a new appreciation of its challenges.
CPEX Pharmaceuticals Inc. today announced that its partner, Serenity Pharmaceuticals, has entered into a global agreement with Allergan, Inc. for the development and commercialization of Ser-120, a product candidate currently in Phase III clinical trials for the treatment of nocturia that utilizes CPEX's patented intranasal drug delivery technology.
Neuros Medical, Inc., a medical device company developing innovative neurostimulation technology for the treatment of chronic pain, announced today a $1.8 million series A round of investment, led by the North Coast Angel Fund (NCAF), which was joined in the investment by Glengary LLC, Ohio Tech Angel Fund, Queen City Angels First Fund III, and individual investors. This round follows the initial investment made earlier in the year from JumpStart Ventures and Case Technology Ventures.
› Verified 4 days ago
| Entity Name | Lancaster Ear Nose And Throat Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962766279 PECOS PAC ID: 1557527017 Enrollment ID: O20120727000219 |
News Archive
iTrace for Blood Centers, (Version 1.0.924.0), the first application to use Radio Frequency Identification technology in blood establishments to assist in enhancing blood safety by preventing the release of unsuitable blood components, was cleared today by the U.S. Food and Drug Administration.
Debt projections released Tuesday by the Congressional Budget Office illustrate three fiscal paths: dangerous, dumb and smart. ... President Obama has called for a balanced solution but has neither proposed serious tax reform nor adequately outlined the ways in which he would get entitlement spending, particularly Medicare, under control. The position of most Republicans, on the presidential campaign trail and in Congress, is wildly less responsible.
Local physicians from Tri-Valley Medical Group recently spent a week in Washington D.C. to discuss the fundamental issues impacting the roll-out of health care reform - and came away with a new appreciation of its challenges.
CPEX Pharmaceuticals Inc. today announced that its partner, Serenity Pharmaceuticals, has entered into a global agreement with Allergan, Inc. for the development and commercialization of Ser-120, a product candidate currently in Phase III clinical trials for the treatment of nocturia that utilizes CPEX's patented intranasal drug delivery technology.
Neuros Medical, Inc., a medical device company developing innovative neurostimulation technology for the treatment of chronic pain, announced today a $1.8 million series A round of investment, led by the North Coast Angel Fund (NCAF), which was joined in the investment by Glengary LLC, Ohio Tech Angel Fund, Queen City Angels First Fund III, and individual investors. This round follows the initial investment made earlier in the year from JumpStart Ventures and Case Technology Ventures.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Karen A Rizzo, MD 930 Red Rose Ct, Suite 301, Lancaster, PA 17601-1981 Ph: (717) 517-9083 | Dr Karen A Rizzo, MD 930 Red Rose Ct, Suite 301, Lancaster, PA 17601-1981 Ph: (717) 517-9083 |
News Archive
iTrace for Blood Centers, (Version 1.0.924.0), the first application to use Radio Frequency Identification technology in blood establishments to assist in enhancing blood safety by preventing the release of unsuitable blood components, was cleared today by the U.S. Food and Drug Administration.
Debt projections released Tuesday by the Congressional Budget Office illustrate three fiscal paths: dangerous, dumb and smart. ... President Obama has called for a balanced solution but has neither proposed serious tax reform nor adequately outlined the ways in which he would get entitlement spending, particularly Medicare, under control. The position of most Republicans, on the presidential campaign trail and in Congress, is wildly less responsible.
Local physicians from Tri-Valley Medical Group recently spent a week in Washington D.C. to discuss the fundamental issues impacting the roll-out of health care reform - and came away with a new appreciation of its challenges.
CPEX Pharmaceuticals Inc. today announced that its partner, Serenity Pharmaceuticals, has entered into a global agreement with Allergan, Inc. for the development and commercialization of Ser-120, a product candidate currently in Phase III clinical trials for the treatment of nocturia that utilizes CPEX's patented intranasal drug delivery technology.
Neuros Medical, Inc., a medical device company developing innovative neurostimulation technology for the treatment of chronic pain, announced today a $1.8 million series A round of investment, led by the North Coast Angel Fund (NCAF), which was joined in the investment by Glengary LLC, Ohio Tech Angel Fund, Queen City Angels First Fund III, and individual investors. This round follows the initial investment made earlier in the year from JumpStart Ventures and Case Technology Ventures.
› Verified 4 days ago
Dr. Francis P Ruggiero, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2160 Noll Dr Ste 200, Lancaster, PA 17603 Phone: 717-481-8720 Fax: 717-481-8726 | |
Dr. Daryl George Bodner, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 810 Plaza Blvd, Lancaster, PA 17601 Phone: 717-394-5088 Fax: 717-394-5590 | |
Dr. Victor Manuel Da Costa, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1430 Harrisburg Pike, Lancaster, PA 17601 Phone: 800-243-1455 Fax: 717-606-1124 | |
Dr. Steven Nolan Dorf, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 810 Plaza Blvd, Lancaster, PA 17601 Phone: 717-394-5088 Fax: 717-394-5590 | |
Dr. John W Miller Iii, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 810 Plaza Blvd, Lancaster, PA 17601 Phone: 717-394-5088 Fax: 717-394-5590 | |
Dr. Joseph Stephen Annese, D.O. Otolaryngology Medicare: Medicare Enrolled Practice Location: 810 Plaza Blvd, Lancaster, PA 17601 Phone: 717-394-5088 Fax: 717-394-5590 |